colorectal cancer: patient follow-up with regorafenib
Published 8 years ago • 498 plays • Length 3:54Download video MP4
Download video MP3
Similar videos
-
2:52
colorectal cancer: patient follow-up with trifluridine/tipiracil
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
9:34
regorafenib in colorectal cancer
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
0:58
managing colorectal cancer in patients who progress on regorafenib
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
5:31
practical advice for using regorafenib
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
-
11:24
managing toxicities associated with regorafenib
-
3:14
when you have decided to prescribe regorafenib
-
6:33
patient selection for regorafenib in crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
11:36
panitumumab, regorafenib, and ziv-aflibercept in metastatic colorectal cancer